The Equipois Trial: A Pragmatic RCT

Thanks, Ross. It's great to be here today back in Belfast and thanks to Robin, the team. I've got to talk about the study design and I'm also going to talk about someone who's involved obviously in running the trial and recruiting a patient in this trial. Hopefully you will see it's not that easy to recruit patients into this study. And it's to their enormous credit that they maintain Equipois sufficient to complete the trial with enrollment of the last patient in September 2021. Thank you.